Russel Burge Selected Research

Russel Burge Research Topics

Disease

36	Psoriasis (Pustulosis Palmaris et Plantaris) 06/2022 - 12/2017
8	Osteoporosis 11/2017 - 03/2013
4	Pain (Aches) 04/2021 - 01/2013
3	Psoriatic Arthritis 04/2022 - 09/2018
3	COVID-19 01/2022 - 11/2021
2	Dyslipidemias (Dyslipidemia) 05/2016 - 04/2009
1	Obesity 11/2021
1	Hypertension (High Blood Pressure) 11/2021
1	Hypercholesterolemia 05/2016
1	Type 2 Diabetes Mellitus (MODY) 05/2016
1	Femoral Neck Fractures 05/2016
1	Hyperglycemia 05/2016
1	Hyperlipidemias (Hyperlipidemia) 05/2016
1	Metabolic Syndrome (Dysmetabolic Syndrome X) 05/2016
1	Atherosclerosis 05/2016
1	Muscular Atrophy (Muscle Atrophy) 04/2015
1	Spontaneous Fractures (Pathological Fracture) 01/2015
1	Rheumatoid Arthritis 01/2015
1	Osteoarthritis 01/2015
1	Muscle Cramp (Cramp) 01/2014
1	Stroke (Strokes) 01/2014
1	Venous Thromboembolism 01/2014
1	Metabolic Bone Diseases (Osteopenia) 01/2014
1	Breast Neoplasms (Breast Cancer) 03/2013
1	Postmenopausal Osteoporosis 03/2013
1	Coronary Disease (Coronary Heart Disease) 04/2009
1	Diabetes Mellitus 04/2009
1	Myocardial Infarction 05/2007

Drug/Important Bio-Agent (IBA)

34	ixekizumabIBA 06/2022 - 12/2017
8	Interleukin-17 (Interleukin 17)IBA 01/2022 - 01/2018
7	Biological ProductsIBA 01/2022 - 12/2019
6	Adalimumab (Humira)FDA Link 04/2022 - 12/2019
6	Etanercept (Enbrel)FDA Link 01/2022 - 12/2017
6	secukinumabIBA 01/2022 - 12/2019
5	Ustekinumab (CNTO 1275)FDA Link 02/2022 - 02/2020
4	Raloxifene Hydrochloride (Evista)FDA Link 11/2017 - 03/2013
3	Pharmaceutical PreparationsIBA 03/2022 - 05/2016
3	Monoclonal AntibodiesIBA 08/2021 - 03/2020
2	guselkumabIBA 03/2022 - 02/2020
2	baricitinibIBA 01/2022 - 11/2021
2	remdesivirIBA 01/2022 - 11/2021
2	Adrenal Cortex Hormones (Corticosteroids)IBA 11/2021 - 01/2015
2	Tumor Necrosis Factor InhibitorsIBA 01/2021 - 02/2020
2	Interleukin-12 (IL 12)IBA 10/2020 - 02/2020
2	InterleukinsIBA 10/2020 - 02/2020
2	Teriparatide (Parathar)FDA Link 11/2017 - 05/2016
2	Alendronate (Alendronate Sodium)FDA LinkGeneric 11/2017 - 03/2013
2	Opioid Analgesics (Opioids)IBA 01/2015 - 01/2013
2	LipidsIBA 01/2014 - 04/2009
1	Immunoglobulin A (IgA)IBA 05/2022
1	Oxygen (Dioxygen)IBA 01/2022
1	Janus Kinase 1IBA 11/2021
1	Certolizumab Pegol FDA Link 02/2020
1	brodalumabIBA 02/2020
1	Interleukin-23 (Interleukin 23)IBA 02/2020
1	risankizumabIBA 02/2020
1	tildrakizumabIBA 02/2020
1	Infliximab (Remicade)FDA Link 02/2020
1	CytokinesIBA 08/2018
1	Etidronic Acid (HEDP)FDA LinkGeneric 11/2017
1	Calcitonin (Calcitonin, Eel)FDA LinkGeneric 11/2017
1	Zoledronic Acid (Zometa)FDA Link 11/2017
1	Pamidronate (Aredia)FDA LinkGeneric 11/2017
1	Denosumab FDA Link 11/2017
1	Diphosphonates (Bisphosphonates)IBA 11/2017
1	tiludronic acid (tiludronate)FDA Link 11/2017
1	Risedronic Acid (Actonel)FDA LinkGeneric 11/2017
1	GlucocorticoidsIBA 05/2016
1	Glucose (Dextrose)FDA LinkGeneric 05/2016
1	Parathyroid Hormone (Parathormone)IBA 05/2016
1	Antidepressive Agents (Antidepressants)IBA 01/2015
1	Anticonvulsants (Antiepileptic Drugs)IBA 01/2015
1	BenzodiazepinesIBA 01/2015
1	Triglycerides (Triacylglycerol)IBA 04/2009
1	CholesterolIBA 04/2009
1	oxidized low density lipoproteinIBA 04/2009
1	LDL CholesterolIBA 04/2009

Therapy/Procedure

8	Therapeutics 03/2022 - 04/2009
3	Length of Stay 11/2021 - 05/2007
2	Biological Therapy 01/2021 - 02/2020
1	Noninvasive Ventilation 01/2022
1	Long-Term Care 11/2021
1	Extracorporeal Membrane Oxygenation 11/2021
1	Time-to-Treatment 11/2017
1	Reoperation 05/2016
1	Hip Replacement Arthroplasty (Total Hip Replacement) 04/2015
1	Coronary Artery Bypass (Coronary Artery Bypass Surgery) 05/2007